Ziqi Chen

274 Middle Zhijiang Road
Shanghai, 200071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Ultrasmall nanosonocatalyst induces PANoptosis to suppress ovarian cancer: From patient-derived organoids to in vivo models.

Ultrasmall nanosonocatalyst induces PANoptosis to suppress ovarian cancer: From patient-derived organoids to in vivo models.

Journal: Biomaterials

Published: April 08, 2026

TSZAF Monomer Combination Inhibits the Progression of Ovarian Cancer Via Regulating the AKT/FOXO3A-mediated Glycolysis Pathway.

TSZAF Monomer Combination Inhibits the Progression of Ovarian Cancer Via Regulating the AKT/FOXO3A-mediated Glycolysis Pathway.

Journal: Biological procedures online

Published: September 03, 2025

Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages.

Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages.

Journal: Cell stress

Published: July 20, 2025

Temporal network analysis of gut microbiota unveils aging trajectories associated with colon cancer.

Temporal network analysis of gut microbiota unveils aging trajectories associated with colon cancer.

Journal: mSystems

Published: April 29, 2025

Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.

Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 31, 2024

Chinese Medicines and Natural Medicine as Immunotherapeutic Agents for Gastric Cancer: Recent Advances.

Chinese Medicines and Natural Medicine as Immunotherapeutic Agents for Gastric Cancer: Recent Advances.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 24, 2024

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis.

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis.

Journal: International journal of biological sciences

Published: November 03, 2023

Paris saponins Ⅶ inhibits glycolysis of ovarian cancer via the RORC/ACK1 signaling pathway.

Paris saponins Ⅶ inhibits glycolysis of ovarian cancer via the RORC/ACK1 signaling pathway.

Journal: Biochemical pharmacology

Published: January 06, 2023

Discovery and structure-activity-relationship study of novel conformationally restricted indane analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors.

Discovery and structure-activity-relationship study of novel conformationally restricted indane analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: August 29, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026